The system integrates streamlined nanoparticle production workflows, an expert mode that allows fine control of detailed conditions within microfluidic channels, and essential equipment maintenance functions. Together, these features significantly reduce the time and cost required for novel drug formulation development.

LNP performance

KRON was founded with the mission of applying the precision and stability of semiconductor-based technologies to the BIO sector, contributing to disease prevention and the development of innovative therapeutic solutions.

By developing advanced microfluidic systems, KRON enables highly precise control of liquids at the microliter (μL) scale, a capability that has been successfully applied across a wide range of applications.

Furthermore, KRON has developed fluidic cartridges optimized for nanoparticle formulation, specifically designed for drug delivery and gene therapy applications, reinforcing its position as a key technology provider in next-generation biopharmaceutical development.